| Identification | Back Directory | [Name]
2,2'-(1,4-Piperazinediyl)bis-pyrimidine | [CAS]
84746-24-7 | [Synonyms]
Buspirone EP Imp G
Buspirone EP Impurity G
1,4-di-pyrimidin-2-yl-piperazine
2,2'-(Piperazine-1,4-diyl)dipyrimid
2,2'-(1,4-Piperazinediyl)bis-pyrimidine
Pyrimidine, 2,2'-(1,4-piperazinediyl)bis-
2-(4-pyrimidin-2-ylpiperazin-1-yl)pyrimidine
Buspirone Impurity 7(Buspirone EP Impurity G)
Piribedil Impurity 1(Tandospirone Impurity 1)
Pipidil Impurity 1 (Tanduropirone Impurity 1)
Buspirone EP Impurity G/ Buspirone Related Compound G
Buspirone Related Compound G (1,4-Di(pyrimidin-2-yl)piperazine) (1078813) | [Molecular Formula]
C12H14N6 | [MDL Number]
MFCD04208147 | [MOL File]
84746-24-7.mol | [Molecular Weight]
242.28 |
| Chemical Properties | Back Directory | [Melting point ]
273-274 °C | [Boiling point ]
480.7±55.0 °C(Predicted) | [density ]
1.276±0.06 g/cm3(Predicted) | [storage temp. ]
Sealed in dry,Room Temperature | [solubility ]
Acetonitrile (Slightly), Chloroform (Slightly), DMSO (Slightly, Heated) | [form ]
Solid | [pka]
5.17±0.33(Predicted) | [color ]
White to Off-White | [Major Application]
pharmaceutical small molecule | [InChI]
1S/C12H14N6/c1-3-13-11(14-4-1)17-7-9-18(10-8-17)12-15-5-2-6-16-12/h1-6H,7-10H2 | [InChIKey]
CGDIIYVMINKXRL-UHFFFAOYSA-N | [SMILES]
N2(CCN(CC2)c3ncccn3)c1ncccn1 |
| Hazard Information | Back Directory | [Uses]
2,2'-(1,4-Piperazinediyl)bis-pyrimidine is an impurity of Buspirone (B689850), an non-benzodiazepine anxiolytic; 5-hydroxytryptamine (5-HT1) receptor agonist. | [Uses]
2,2’-(1,4-Piperazinediyl)bis-pyrimidine is an impurity of Buspirone (B689850), an non-benzodiazepine anxiolytic; 5-hydroxytryptamine (5-HT1) receptor agonist. |
|
| Company Name: |
J & K SCIENTIFIC LTD.
|
| Telephone: |
18210857532 18210857532 |
| Website: |
https://www.jkchemical.com |
| Company Name: |
Roark Standards
|
| Telephone: |
0755-83552066 15986688328 |
| Website: |
roarkstandards.com |
| Company Name: |
TOSUN PHARM
|
| Telephone: |
020-66392521-118 18922260391 |
| Website: |
www.toref.cn/ |
|